Lavipharm A.E.
- C01 - Terapia cardíaca
- NITRONG transdermal patch 10 mg/24 h (14 cm²)
- NITRONG transdermal patch 5 mg/24 h (7 cm²)
- N02 - Analgésicos
- LAVIFENT transdermal patch 100 µg/h
- LAVIFENT transdermal patch 25 µg/h
- LAVIFENT transdermal patch 50 µg/h
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- THEO-DUR prolonged-release tablet 200 mg
- THEO-DUR prolonged-release tablet 300 mg